A systematic literature review of prognostic factors in patients with HR+/HER2- advanced breast cancer in Japan.
Masaya HattoriDiego NovickKana TakauraYoshinori TanizawaTsutomu KawaguchiJosep Maria HaroAnna Monistrol-MulaAkira OnishiHiroji IwataPublished in: Japanese journal of clinical oncology (2021)
Disease-free interval, the number of metastatic organs and liver metastasis were identified as independent prognostic factors for overall survival. These findings may help clinical decision-making to improve outcomes in patients with HR+/HER2- advanced and metastatic breast cancer.